Patents expiring in 2032

US 8110569

Enantiomerically pure S-etifoxine, pharmaceutical compositions thereof and methods of their use

The Regents of the University of California · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110209

Intracutaneous injection

XERIS PHARMACEUTICALS, INC. · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110352

Method of diagnosing and treating cancer using B-catenin splice variants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110651

Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same

Serina Therapeutics, Inc. · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110674

Therapeutic compositions

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110354

Use of Shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo

The United States of America as represented by the Secretary of the Army · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8111019

Sensing type control circuit for electronic apparatus

Princeton Technology Corporation · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8110192

Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

DE 102010033527

Quetiapin-Tabletten

ACINO PHARMA AG [CH] · Granted Thu Feb 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Feb 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114835

Self-assembling peptide amphiphiles for tissue engineering

Northwestern University · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114834

Self-assembling peptide amphiphiles

Northwestern University · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8115011

Diacylglycerol acyltransferase inhibitors

Madrigal Pharmaceuticals, Inc. · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114848

Immunomodulatory oligonucleotides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114406

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114390

Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefore

Arizona Board of Regents on Behalf of the University of Arizona · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114620

Diagnostic and therapeutic target PRKX proteins for neurodegenerative diseases

Takeda Pharmaceutical Company Limited · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114618

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114394

Use of IL-1 antagonists to treat gout

REGENERON PHARMACEUTICALS, INC. · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114648

In vivo incorporation of unnatural amino acids

The Regents of the University of California · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114590

Diagnosis and treatment of chronic lymphocytic leukemia (CLL)

The Regents of the University of California · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114830

Polypeptoid pulmonary surfactants

Northwestern University · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114852

N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114984

RNAi modulation of Aha and therapeutic uses thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114981

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114843

Photoreactive regulator of protein function and methods of use thereof

The Regents of the University of California · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114851

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114446

Methods for modulating eicosanoid metabolism

The Board of Regents of the University of Texas System · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8114900

Amorphous carvedilol dihydrogen phosphate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Feb 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119590

Prevention and treatment of restenosis by local administration of drug

Esperion Therapeutics, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119642

Structurally rigid dopamine D3 receptor selective ligands and process for making them

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119655

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119809

AMPK-activating heterocycloalkyloxy(hetero)aryl carboxamide, sulfonamide and amine compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119779

Phosphoramidate derivatives

University College Cardiff Consultants Limited · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119634

Dual-acting pyrazole antihypertensive agents

Theravance, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119772

MART-1 T cell receptors

The Regents of the University of California · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119827

Compounds for treatment of cell proliferative diseases

The Board of Regents of the University of Texas System · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119796

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119769

Complement depletion using recombinant human C-3 derivatives

PLS-Design GmbH · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119649

Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemia

The Board of Regents of the University of Texas System · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119631

Inhibitors of interleukin-1β converting enzyme

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119618

Compositions and methods for the treatment of inflammatory diseases

The Board of Regents of the University of Oklahoma · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119398

Adipose-derived stem cells for tissue regeneration and wound healing

PrimeGen Biotech LLC · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119608

Method and medicament for inhibiting the expression of a given gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119660

Small-molecule inhibitors of the androgen receptor

The Regents of the University of California · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8119656

Inhibitors of the influenza virus non-structural 1 protein

The Board of Regents of the University of Texas System · Granted Tue Feb 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8123541

Electrical connector with expanded cover

Hon Hai Precision Ind. Co., Ltd. · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8124781

Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

Vertex Pharmaceuticals Incorporated · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

US 8124627

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Feb 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)